Related Experiment Videos
BioForce Nanosciences, Inc.
1BioForce Nanosciences, Inc., Ames, IA 50010, USA. ehenderson@bioforcenano.com
Nanomedicine (London, England)
|August 25, 2007
Summary
BioForce Nanosciences offers nanotechnology tools for life sciences. Their Nano eNabler system enables advanced applications like pathogen detection and cancer biomarker analysis.
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Distal symmetric diabetic neuropathy.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same author
Evaluation of analytical models to estimate depth of fluorescence objects in biological media.
Journal of biomedical optics·2026
Same author
Sex and gender differences in upper extremity prosthesis rejection: A review of literature.
Prosthetics and orthotics international·2024
Same author
Intraoperative molecular imaging: 3rd biennial clinical trials update.
Journal of biomedical optics·2023
Same author
Treatment Guideline Nonadherence Pretransport Associated With Need for Higher Level of Care in Children Transferred to a Pediatric Tertiary Care Center for Status Epilepticus.
Pediatric emergency care·2023
Same author
Fluorescence-guided and molecularly-guided debridement: identifying devitalized and infected tissue in orthopaedic trauma.
Proceedings of SPIE--the International Society for Optical Engineering·2023
Same journal
Phase I first-in-human dose-escalation trial of a bladder cancer-specific nanoparticle in non-muscle-invasive bladder cancer.
Nanomedicine (London, England)·2026
Same journal
From conventional formulations to nanoparticles in the delivery of Imiquimod: a literature review.
Nanomedicine (London, England)·2026
Same journal
Lipid-based nanocarriers as transformative treatment in tuberculosis: a systematic review of therapeutic efficacy.
Nanomedicine (London, England)·2026
Same journal
UCMSC-Exo for chemotherapy-induced myelosuppression in acute myeloid leukemia: a phase I clinical trial protocol.
Nanomedicine (London, England)·2026
Same journal
Aptamer-functionalized nanoparticles for cancer targeting: conjugation strategies, current applications and future perspectives.
Nanomedicine (London, England)·2026
Same journal
Targeted therapy of highly aggressive thyroid papillary carcinoma by AS1411-guided nanomaterials.
Nanomedicine (London, England)·2026